GlassScriptPhysician profile
Francine Dimaria
NPI 1144297045
$7,646.44
in general payments reported to CMS, 2019-2025
39 companies · $718 in 2025
The $718 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,366 · 2020: $1,131 · 2021: $1,512 · 2022: $1,307 · 2023: $835 · 2024: $778 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,330.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,276.51 | 2019-2025 | Vraylar, Ubrelvy, Synthroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $961.74 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $714.48 | 2019-2025 | Airsupra, Farxiga |
| Amgen INC. | $483.68 | 2019-2025 | Repatha, Otezla, Repatha |
| Novo Nordisk INC | $430.95 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $409.89 | 2019-2023 | Jardiance, Emgality, Mounjaro |
| Glaxosmithkline, LLC. | $391.36 | 2021-2025 | Trelegy Ellipta |
| Amarin Pharma, INC. | $362.28 | 2019-2022 | |
| Pfizer INC. | $347.12 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $254.88 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Janssen Pharmaceuticals, INC | $229.95 | 2019-2024 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $198.87 | 2019-2025 | Zoryve |
| Inspire Medical Systems, INC. | $148.64 | 2025 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $146.38 | 2022 | |
| Arbor Pharmaceuticals, INC. | $139.26 | 2019-2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francine Dimaria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.